Blog

With the American Society of Clinical Oncology (ASCO) 2022 coming to an end and being blown away by the development of innovative precision medicines, I couldn’t help but reflect on the challenges ahead for cancer services and the need to address them in order to effectively implement these new treatments. In their 2022/23 priorities and … Continued

On November 3rd 2017 the UK Government published its endorsement of the Accelerated Access Review (Making a reality of the Accelerated Access Review: Improving patient access to breakthrough technologies and treatments in a cost-effective model). At the core of the Accelerated Access Review is the proposal to get strategically important, cost-effective products into the NHS as … Continued

The digital revolution has arrived. New technology and advanced analytics are transforming how the pharmaceutical industry works, competes and engages with customers. How then can you get ahead of the curve? Health system efficiencies As new and increasingly innovative medicines provide more opportunities for treatment options in previously unmet areas of need, patient access can … Continued

The sales aid is dead, long live the value proposition! Controversial? Yes! I’ve been banging the drum for market access for well over decade. Those who know me well will know that drum is pretty loud! Market access is my passion (I’m serious!), so no surprises then at my opening line. Today my drum is … Continued

Disruptor! The word in itself is disruptive. But what exactly does it mean? Is it a negative attribute? And how is it relevant in the context of healthcare? Disruptor in the business world is synonymous with Professor Clayton Christensen’s theory of disruptive innovation. His theory has specific criteria on market entry, enabling the build of … Continued